All Posts
July 16, 2026
Factors Influencing CAR-T Therapy Pricing in China
What drives the cost of CAR-T cell therapy in China, from manufacturing complexity and regulation to insurance, competition, and typical price ranges.
Read more →July 15, 2026
TIVDAK (Tisotumab Vedotin) — ADC for Recurrent Cervical Cancer
TIVDAK is a Tissue Factor-targeting ADC, opening a new option for patients with recurrent or metastatic cervical cancer after prior chemotherapy.
Read more →July 15, 2026
CyberKnife for Lung Tumors: A Radiation Oncologist's In-Depth Explanation
How CyberKnife SBRT treats lung tumors non-invasively while tracking breathing motion, illustrated by three real lung cancer cases with strong outcomes.
Read more →July 14, 2026
Larotrectinib (Vitrakvi) — NTRK Fusion-Targeted Drug Effective Across Cancer Types
Larotrectinib is an NTRK gene fusion inhibitor effective regardless of tumour tissue type. The tumor-agnostic model opens a new era of genomics-based treatment.
Read more →July 14, 2026
Hospital Guide: Golden Light International Medical Department, Shanghai
A guide to Golden Light International Medical Department in Shanghai, blending Western technology with Traditional Chinese Medicine, sports rehab, and acupuncture.
Read more →July 13, 2026
Cancer Overview — Causes, Classification and Modern Treatment Approaches
A basic understanding of cancer: how cancer cells form, risk factors, tissue-origin classification and modern treatment approaches including immunotherapy and CAR-T.
Read more →July 13, 2026
Information on Lymphoma
An overview of lymphoma: its rising incidence, Hodgkin vs. non-Hodgkin types, symptoms, treatments including CAR-T, and prevention.
Read more →July 12, 2026
Lung Cancer — Symptoms, Diagnosis and Advanced Treatment Options in China
Lung cancer is the leading cause of cancer death worldwide. Understanding its symptoms, classification and advanced treatment technologies (TKI, immunotherapy, Proton therapy) can improve outcomes.
Read more →July 12, 2026
The "Lazy Cancer" That Isn't: Fighting Thyroid Cancer's Deadliest Form
Most thyroid cancers are slow and highly treatable, but Anaplastic Thyroid Carcinoma (ATC) allows only months of survival. A multi-disciplinary team saved a case deemed inoperable.
Read more →July 11, 2026
Cancer Treatment in Singapore — What You Need to Know (Coming Soon)
Singapore is Southeast Asia's leading medical destination with world-class hospitals. HomeMed is developing accompaniment services to Singapore — coming soon.
Read more →July 11, 2026
CMICS: The Leap and Rebalancing of Minimally Invasive Cardiovascular Surgery in China
In just six years, China's minimally invasive cardiovascular surgery has leapt from concept popularization to system restructuring, narrowing regional gaps.
Read more →July 10, 2026
Active Post-Treatment Cancer Care — Effective Relapse Prevention
Cancer treatment does not end at discharge. Active post-treatment care — regular monitoring, nutrition and timely follow-ups — plays a crucial role in relapse prevention.
Read more →